Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Receivables (2016 - 2025)

iBio (IBIO) has disclosed Receivables for 14 consecutive years, with $65000.0 as the latest value for Q3 2025.

  • Quarterly Receivables changed N/A to $65000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $1.0 million for FY2022, 90.2% down from the prior year.
  • Receivables for Q3 2025 was $65000.0 at iBio, down from $5.1 million in the prior quarter.
  • The five-year high for Receivables was $15.4 million in Q1 2021, with the low at $65000.0 in Q3 2025.
  • Average Receivables over 4 years is $5.9 million, with a median of $5.1 million recorded in 2021.
  • The sharpest move saw Receivables soared 16269.15% in 2021, then crashed 93.06% in 2022.
  • Over 4 years, Receivables stood at $5.1 million in 2021, then plummeted by 80.98% to $970000.0 in 2022, then soared by 425.77% to $5.1 million in 2023, then crashed by 98.73% to $65000.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $65000.0, $5.1 million, and $970000.0 for Q3 2025, Q1 2023, and Q4 2022 respectively.